These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1661847

  • 1. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW, Plaeger-Marshall S, Ank BJ, Pressman SR, Stiehm ER.
    Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
    [Abstract] [Full Text] [Related]

  • 2. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ, Bochan MR, Montel A, Padilla LM, Brahmi Z.
    Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
    [Abstract] [Full Text] [Related]

  • 3. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 4. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 5. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG, Zeuthen J, Claësson MH.
    Nat Immun; 1992 Oct; 11(1):7-16. PubMed ID: 1611282
    [Abstract] [Full Text] [Related]

  • 6. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 7. Human newborn natural killer cell responses to activation by monoclonal antibodies. Effect of culture with herpes simplex virus.
    Hayward A, Laszlo M, Vafai A.
    J Immunol; 1989 Feb 15; 142(4):1139-43. PubMed ID: 2536766
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
    Teichmann JV, Ludwig WD, Thiel E.
    Nat Immun; 1992 Feb 15; 11(3):117-32. PubMed ID: 1392400
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR, Asuncion M, Fons M, Norton JD, Albrecht T, Klimpel KD, Stein MD.
    J Clin Lab Immunol; 1989 May 15; 29(1):1-7. PubMed ID: 2560794
    [Abstract] [Full Text] [Related]

  • 10. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood].
    Li Y, Huang SL, Wu YF, Wei J, Meng Y, Zhou DH, Bao R.
    Zhonghua Xue Ye Xue Za Zhi; 2005 May 15; 26(5):269-72. PubMed ID: 15949286
    [Abstract] [Full Text] [Related]

  • 11. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul 15; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 May 01; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 19. Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
    Kohl S.
    J Immunol; 1990 Jan 01; 144(1):307-12. PubMed ID: 2153165
    [Abstract] [Full Text] [Related]

  • 20. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV, McKean DJ, Segal DM, Schoon RA, Showalter SD, Leibson PJ.
    J Immunol; 1989 Jan 15; 142(2):666-71. PubMed ID: 2536060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.